🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

63,60 USD

Máx. histórico

108,06

1031 días

Split 1:6 del 25/06/2013

Caída desde máximo

-41,14%

Rango 52 semanas

58,05 – 88,31

Variación hoy

+2,07%

Cierre anterior

62,31

Rango de hoy

60,98 – 64,95

Volumen hoy

2.686.320

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,37%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 23 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/09/2021 33,00 34,00 32,40 33,70 +1,81% 4,85% 853.300
14/09/2021 31,77 33,43 30,79 33,10 +5,15% 8,31% 1.372.600
13/09/2021 29,40 32,29 29,10 31,48 +6,64% 10,85% 1.423.600
10/09/2021 30,09 30,53 29,40 29,52 -1,76% 3,76% 843.500
09/09/2021 31,43 31,70 29,80 30,05 -3,44% 6,05% 1.536.700
08/09/2021 30,96 31,35 30,50 31,12 +0,23% 2,75% 637.600
07/09/2021 33,11 33,11 30,95 31,05 -4,34% 6,52% 995.900
03/09/2021 32,66 33,71 32,02 32,46 -3,16% 5,17% 1.081.700
02/09/2021 33,38 33,85 32,73 33,52 +1,51% 3,36% 485.800
01/09/2021 32,94 33,64 32,52 33,02 +0,15% 3,40% 1.005.800
31/08/2021 32,73 33,39 32,20 32,97 +0,95% 3,64% 643.400
30/08/2021 33,13 34,32 32,30 32,66 -1,86% 6,10% 1.369.300
27/08/2021 31,59 34,17 31,59 33,28 +5,45% 8,17% 1.287.200
26/08/2021 31,51 32,35 31,22 31,56 -1,25% 3,59% 844.600
25/08/2021 31,38 32,19 31,12 31,96 +1,33% 3,41% 559.200
24/08/2021 31,28 31,90 30,79 31,54 +0,48% 3,55% 426.600
23/08/2021 30,56 31,50 30,42 31,39 +2,72% 3,53% 776.800
20/08/2021 29,87 30,74 29,86 30,56 +1,87% 2,95% 653.800
19/08/2021 30,08 30,93 29,94 30,00 -0,83% 3,29% 723.800
18/08/2021 31,57 31,75 30,22 30,25 -4,75% 4,85% 595.100
17/08/2021 31,00 32,01 30,73 31,76 +1,93% 4,13% 636.100
16/08/2021 31,58 32,20 30,92 31,16 -3,08% 4,05% 630.700
13/08/2021 32,86 32,95 32,01 32,15 -0,86% 2,86% 570.500
12/08/2021 32,60 32,80 31,82 32,43 -0,31% 3,01% 462.300
11/08/2021 31,44 32,71 31,33 32,53 +1,88% 4,39% 505.200
10/08/2021 32,21 32,21 31,11 31,93 +0,13% 3,42% 929.600
09/08/2021 31,59 32,97 31,31 31,89 +0,22% 5,25% 1.403.700
06/08/2021 29,51 32,49 29,17 31,82 +5,22% 11,25% 1.126.100
05/08/2021 29,53 31,00 28,66 30,24 +2,47% 7,92% 903.800
04/08/2021 28,84 29,95 28,84 29,51 +2,36% 3,85% 930.800